The World Health Organization is now using IOM’s innovative Security Communications and Analysis Network (SCAAN) in the Democratic Republic of the Congo (DRC) to support the security of its staff fighting the Ebola epidemic.
Advertisements
Diseases
Study explains behavioral reaction to painful experiences
Exposure to uncomfortable sensations elicits a wide range of appropriate and quick reactions, from reflexive withdrawal to more complex feelings and behaviors.
Of all human diseases, 60% originate in animals – “One Health” is the only way to keep antibiotics working
Antibiotic resistance is a growing threat to global health. As a result of infection with drug-resistant bacteria an estimated 700 000 people die each year worldwide. A total of around 33 000 die annually in the European Union and European Economic Area, and this number is increasing all the time.
NIH scientists combine technologies to view the retina in unprecedented detail
By combining two imaging modalities — adaptive optics and angiography — investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye’s light-sensing retina.
NIH scientists illuminate causes of hepatitis b virus-associated acute liver failure
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF) — a rare condition that can turn fatal within days without liver transplantation — results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response in the patient’s liver that is mainly sustained by antibody-producing B cells.
NIAID-Funded Researchers Predict TB Relapse Risk
The consequences of TB relapse can reach beyond an individual patient, as any bacteria that remain in the patient after treatment has ended are more likely to be resistant to antibiotics.
Finnish study lengthened lives by changing lifestyles
Project director Pekka Puska, a physician, researcher, and member of the Finnish parliament, recently spoke to a Harvard T.H. Chan School of Public Health audience about the project’s history and its implications for global cardiovascular disease prevention and policy.
